|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 94, 504-509, Copyright © 1987 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
N Roeslin, G Chalkiadakis, P Dumont and JP Witz
This prospective study analyzes the survival rate, according to TNM and
staging, of 538 patients who underwent curative pulmonary resection for
non-oat cell tumors and who survived the operative period. A total of 279
patients had Stage I disease, 113 Stage II, and 146 Stage III. The overall
survival rates were 72% at 1 year, 54% at 2 years, 47% at 3 years, 43% at 4
years, and 39% at 5 years. The survival curves of Stages I, II, and III are
significantly different. Nevertheless, in Stage I, T1 N0 tumors presented
the best survival rate (71% at 5 years), and this was significantly
different from those of all other groups. For Stage II, the survival curves
were significantly different according to hilar or lobar location of N1.
The survival rate of T2 N1 hilar tumors was similar to that of T2 N2
tumors. In Stage III, the survival of T3 N2 tumors was the worst of all
classifications. These results may contribute to a reappraisal of the
surgical classification. T1 N0 tumors are worthy, on their own, of forming
Stage I. T2 N0, T1 N1 lobar, and T2 N1 lobar can constitute Stage II. Stage
III or IIIa would comprise carcinomas classified T2 N1 hilar, T1 N2, T2 N2,
and perhaps T3 N0 and T3 N1. T3 N2 should probably be isolated in a IIIb or
IV stage.
ARTICLES
A better prognostic value from a modification of lung cancer staging
Service de Chirurgie Thoracique, C.H.U. de Strasbourg, France.
This article has been cited by other articles:
![]() |
H. Asamura, K. Suzuki, H. Kondo, and R. Tsuchiya Where is the boundary between N1 and N2 stations in lung cancer? Ann. Thorac. Surg., December 1, 2000; 70(6): 1839 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Massard, R. Kessler, B. Gasser, X. Ducrocq, S. Elia, S. Gouzou, and J.-M. Wihlm Local control of disease and survival following bronchoplastic lobectomy for non-small cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 1999; 16(3): 276 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Massard, A. Dabbagh, P. Dumont, R. Kessler, N. Roeslin, J.-M. Wihlm, and G. Morand Are Bilobectomies Acceptable Procedures? Ann. Thorac. Surg., September 1, 1995; 60(3): 640 - 645. [Abstract] [Full Text] |
||||
![]() |
T. Funatsu, Y. Matsubara, S. Ikeda, R. Hatakenaka, T. Hanawa, and H. Ishida Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 321 - 328. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |